EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease ? A systematic review, meta‐analysis, and meta‐regression

Jerónimo Aragón-Vela, Antonio J Sánchez-Oliver, Jesús R Huertas, Rafael A Casuso

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8274 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Jerónimo Aragón-Vela und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Area of Physiology, University of Jaen, Jaén, Spain. Hauptthemen laut MEDLINE: Curcumin, Non-alcoholic Fatty Liver Disease, Alanine Transaminase, Aspartate Aminotransferases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this meta‐analysis is to investigate the sources of heterogeneity in randomized clinical trials examining the effects of curcumin supplementation on liver aminotransferases in subjects with nonalcoholic fatty liver disease (NAFLD). We conducted a systematic search of the PubMed, SCOPUS, and Web of Science databases for randomized clinical trials and identified 15 studies ( n = 835 subjects). We used random‐effects models with DerSimonian‐Laird methods to analyze the serum levels of alanine aminotransferase and aspartate aminotransferase enzymes. Our results indicate that curcumin did not affect serum alanine aminotransferase, but it did reduce aspartate aminotransferase levels. Notably, both outcomes showed high heterogeneity ( p < 0.01). Subgroup analysis revealed that adding piperine to curcumin did not benefit aminotransferase levels in NAFLD patients. Additionally, we found a negative correlation between the duration of the intervention and the relative (mg/kg/day) curcumin dose with the reduction in liver aminotransferases. In summary, the sources of heterogeneity identified in our study are likely attributed to the duration of the intervention and the relative dose of curcumin. Consequently, longer trials utilizing high doses of curcumin could diminish the positive impact of curcumin in reducing serum levels of aminotransferases in patients with NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminNon-alcoholic Fatty Liver DiseaseAlanine TransaminaseAspartate AminotransferasesLiverHumansPolyunsaturated AlkamidesRandomized Controlled Trials as TopicPiperidinesBenzodioxolesAlkaloids

Stichwörter der Autor:innen

aminotransferasesnonalcoholic fatty liver diseaseobesitypiperinepolyphenol

Substanzen

CurcuminAlanine TransaminaseAspartate AminotransferasesPolyunsaturated AlkamidesPiperidinespiperineBenzodioxolesAlkaloids

Autor:innen und Institutionen

  • Department of Health Sciences, Area of Physiology, University of Jaen, Jaén, Spain.
  • Departamento de Motricidad Humana y Rendimiento Deportivo, Facultad de Ciencias de la Educación, Universidad de Sevilla, Sevilla, Spain.
  • Institutes of Nutrition and Food Technology, Department of Physiology, University of Granada, Granada, Spain.
  • Department of Health Sciences, Universidad Loyola Andalucía, Córdoba, Spain.

Förderung

  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Aragón-Vela, J., Sánchez-Oliver, A. J., Huertas, J. R., & Casuso, R. A. (2024). Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease ? A systematic review, meta‐analysis, and meta‐regression. Phytotherapy Research. https://doi.org/10.1002/ptr.8274

Vancouver

Aragón-Vela J, Sánchez-Oliver AJ, Huertas JR, Casuso RA. Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease ? A systematic review, meta‐analysis, and meta‐regression. Phytotherapy Research. 2024. doi:10.1002/ptr.8274

BibTeX
@article{AragnVela2024,
  author = {Aragón-Vela, Jerónimo and Sánchez-Oliver, Antonio J and Huertas, Jesús R and Casuso, Rafael A},
  title = {Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease ? A systematic review, meta‐analysis, and meta‐regression},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8274}
}
Kostenlos starten →